Naringenin attenuated DKD through its anti‐inflammatory and antifibrotic activities by decreasing the expression of IL‐1β, IL‐6, fibronectin, type IV collagen, and TGF‐β1 (Salehi et al. 2019). Here, IL6 is linked to diabetic kidney disease.